A detailed history of Bank Of America Corp transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 149 shares of TARA stock, worth $266. This represents 0.0% of its overall portfolio holdings.

Number of Shares
149
Holding current value
$266
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.96 - $4.14 $292 - $616
149 New
149 $0
Q4 2023

Feb 14, 2024

BUY
$1.12 - $1.93 $6 - $11
6 New
6 $0
Q4 2022

Feb 10, 2023

BUY
$2.43 - $3.7 $53 - $81
22 New
22 $0
Q1 2022

May 16, 2022

SELL
$4.19 - $6.9 $25,697 - $42,317
-6,133 Reduced 89.17%
745 $3,000
Q4 2021

Feb 08, 2022

BUY
$6.15 - $7.76 $39,089 - $49,322
6,356 Added 1217.62%
6,878 $47,000
Q3 2021

Nov 15, 2021

SELL
$6.38 - $9.3 $2,615 - $3,813
-410 Reduced 43.99%
522 $3,000
Q2 2021

Sep 13, 2021

BUY
$8.68 - $16.99 $8,089 - $15,834
932 New
932 $9,000

Others Institutions Holding TARA

About Protara Therapeutics, Inc.


  • Ticker TARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,267,400
  • Market Cap $20.2M
  • Description
  • Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...
More about TARA
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.